The 2 Minute Medicine Podcast Episode 21
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this ...
Tag: malaria
The Scan by 2 Minute Medicine®: Tranquilizer Tales, Naloxone: Overturning Opioid Overdoses, Nicotine Nightmares, and Newly Approved Malaria Vaccine
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
Treatment with dihydroartemisinin-piperaquine does not improve pregnancy outcomes in women with malaria
1. Adverse pregnancy outcomes were less frequent among patients in the sulfadoxine-pyrimethamine group. 2. Differences in adverse pregnancy outcomes were ...
Monoclonal antibody CIS43LS efficacious in preventing malaria in Mali
1. The monoclonal antibody CIS43LS was associated with dose-dependent protection against malaria infection in adults in Mali. 2. CIS43LS had ...
Monoclonal antibody L9LS prevents malaria infection in adults
1. In this small phase one clinical trial, L9LS administration protected healthy adults from contracting a malarial infection. 2. No ...
Higher-dose primaquine has higher efficacy in preventing relapse of Plasmodium vivax malaria
1. Compared to lower dose primaquine, higher dose primaquine had higher efficacy in preventing relapse of Plasmodium vivax malaria. 2. ...
Chlorfenapyr insecticidal nets provide strong protection against malaria in sub-Saharan Africa
1. Chlorfenapyr LLINs provided significantly better protection than pyriproxyfen and piperonyl-butoxide subtypes. 2. Chlorfenapyr LLINs costed an additional $19 US ...
Mosquito Nets Provide Survival Benefit in Early Childhood and into Adulthood
1. In children, the use of mosquito nets for malaria control in early childhood was shown to be associated with ...
#VisualAbstract: Novel malaria vaccine candidate (R21/MM) is safe and highly protective against malaria transmission in African children
1. Vaccine efficacy at 6 months for R21/MM was 74% in group 1 and 77% in group 2. 2. R21/MM showed ...
Novel malaria vaccine candidate (R21/MM) is safe and highly protective against malaria transmission in African children
1. Vaccine efficacy at 6 months for R21/MM was 74% in group 1 and 77% in group 2. 2. R21/MM ...
